TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 79 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,000 | +100.0% | 22,374 | +338.7% | 0.00% | – |
| Q4 2018 | $6,000 | -81.2% | 5,100 | +2.0% | 0.00% | – |
| Q4 2017 | $32,000 | -94.9% | 5,000 | -92.0% | 0.00% | -100.0% |
| Q4 2015 | $629,000 | +18.9% | 62,725 | -11.6% | 0.00% | 0.0% |
| Q3 2015 | $529,000 | -74.5% | 70,925 | +62.0% | 0.00% | -75.0% |
| Q2 2015 | $2,077,000 | +76.9% | 43,778 | +36.7% | 0.00% | +100.0% |
| Q1 2015 | $1,174,000 | – | 32,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 354,300 | $7,068,000 | 2.77% |
| Opaleye Management Inc. | 169,700 | $3,385,515,000 | 2.64% |
| Broadfin Capital, LLC | 959,247 | $19,137,000 | 2.01% |
| Novo Holdings A/S | 900,000 | $17,955,000 | 1.75% |
| Eventide Asset Management | 300,900 | $6,003,000 | 0.84% |
| EAM Investors, LLC | 152,595 | $3,044,000 | 0.62% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 497,858 | $9,932,000 | 0.51% |
| Granite Point Capital Management, L.P. | 40,000 | $798,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,191 | $8,981,000 | 0.33% |
| TFS CAPITAL LLC | 133,070 | $2,655,000 | 0.23% |